Best Practices in Intrathecal Therapy for Chronic Pain
Patient Selection, Treatment Initiation, and Ongoing Monitoring
An Overview of Intrathecal Drug Delivery
Patient Perspectives
Replacement of an Intrathecal Catheter
Medical practice perspective: identification and mitigation of risk factors for mortality associated with intrathecal opioids for non-cancer pain.
Coffey RJ, et al. Pain Med. 2010;11(7):1001-9. (Replacement for deleted article below) doi: 10.1111/j.1526-4637.2010.00889.x.
Intrathecal Ziconotide and Opioid Combination Therapy for Noncancer Pain: an Observational Study
Deer TR, et al. Pain Physician. 2009;12(4):E291-E296.
A Predictive Model for Intrathecal Opioid Dose Escalation for Chronic Non-Cancer Pain
Duarte RV, et al. Pain Physician. 2012;15(5):363-369
Prospective Study of 3-Year Follow-up of Low-Dose Intrathecal Opioids in the Management of Chronic Nonmalignant Pain
Hamza M, et al. Pain Med. 2012;13(10):1304-1313.
Long-term Outcomes Using Intrathecal Drug Delivery Systems in Complex Regional Pain Syndrome.
Herring EZ, et al. Pain Med. 2018 Jun 7. doi: 10.1093/pm/pny104. [Epub ahead of print]
Effectiveness and Safety of Intrathecal Ziconotide: Interim Analysis of the Patient Registry of Intrathecal Ziconotide Management (PRIZM).
Deer T, et al. Pain Pract. 2018;18(2):230-238. doi: 10.1111/papr.12599.
Androgen Deficiency in Long-term Intrathecal Opioid Administration
Kim CH, et al. Pain Physician. 2014;17(4):E543-E548.
Use of Low Dose Ziconotide as First-Line Intrathecal Monotherapy.
Prusik J, et al. Neuromodulation. 2017;20(4):386-391. doi: 10.1111/ner.12486.
Practical Considerations and Patient Selection for Intrathecal Drug Delivery in the Management of Chronic Pain
Saulino M, et al. J Pain Res. 2014;7:627-638.
Safety and Efficacy of Intrathecal Ziconotide in the Management of Severe Chronic Pain
Smith HS, Deer TR. Ther Clin Risk Manag. 2009;5(3):521-534.
Long-term Intrathecal Ziconotide for Chronic Pain: an Open-Label Study
Webster LR, et al. J Pain Symptom Manage. 2009;37(3):363-372.
Clinical Accuracy and Safety Using the SynchroMed II Intrathecal Drug Infusion Pump
Wesemann K, et al. Reg Anesth Pain Med. 2014;39(4):341-346.
Programmable Intrathecal Pumps for the Management of Chronic Pain: Recommendations for Improved Efficiency
Wilkes D. J Pain Res. 2014;7:571-577.
Guidelines
Polyanalgesic Consensus Conference—2012: Recommendations on Trialing for Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel
Deer TR, et al. Neuromodulation. 2012;15(5):420-435.
Polyanalgesic Consensus Conference—2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel
Deer TR, et al. Neuromodulation. 2012;15(5):436-464.
Polyanalgesic Consensus Conference—2012: Recommendations to Reduce Morbidity and Mortality in Intrathecal Drug Delivery in the Treatment of Chronic Pain
Deer TR, et al. Neuromodulation. 2012;15(5):467-482.
Polyanalgesic Consensus Conference—2012: Consensus on Diagnosis, Detection, and Treatment of Catheter-Tip Granulomas (Inflammatory Masses)
Deer TR, et al. Neuromodulation. 2012;15(5):483-495.
The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines.
Deer TR, et al. Neuromodulation. 2017;20(2):96-132.
The Polyanalgesic Consensus Conference (PACC): Recommendations for Trialing of Intrathecal Drug Delivery Infusion Therapy.
Deer TR, et al. Neuromodulation. 2017;20(2):133-154.
Best Practices for Intrathecal Drug Delivery for Pain
Prager J, et al. Neuromodulation. 2014;17(4):354-372.
Evolving Best Practices With Intrathecal Analgesics
Improving the Care of Patients With Severe Chronic Pain
| Faculty: | Timothy R. Deer, MD, DABPM; Jason E. Pope, MD, DABPM, FIPP |
| Release: | 11/09/2016 |
| Expiration: | 11/09/2017 |
Intrathecal Drug Delivery for Chronic Pain
Evolving Best-Practice Strategies to Maximize Efficacy and Safety
| Faculty: | Timothy R. Deer, MD, DABPM |
| Release: | 12/19/2016 |
| Expiration: | 12/19/2017 |
Overview of Intrathecal Therapy For Chronic Pain
Module 1
| Faculty: | Charles E. Argoff, MD; Timothy R. Deer, MD, DABPM |
| Release: | 08/15/2018 |
| Expiration: | 08/15/2019 |
Selecting Patients Who May Benefit From Intrathecal Drug Delivery For Severe Chronic Pain
Module 2
| Faculty: | Charles E. Argoff, MD; Timothy R. Deer, MD, DABPM |
| Release: | 08/15/2018 |
| Expiration: | 08/15/2019 |
Initiating Intrathecal Therapy For Patients With Severe Chronic Pain
Module 3
| Faculty: | Charles E. Argoff, MD; Timothy R. Deer, MD, DABPM |
| Release: | 08/15/2018 |
| Expiration: | 08/15/2019 |
Long-Term Monitoring Of Patients Treated With Intrathecal Analgesics
Module 4
| Faculty: | Charles E. Argoff, MD; Timothy R. Deer, MD, DABPM |
| Release: | 08/15/2018 |
| Expiration: | 08/15/2019 |
